SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-018556
Filing Date
2023-05-17
Accepted
2023-05-17 07:43:23
Documents
1
Period of Report
2023-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1684323794.html 4  
1 FORM 4 wk-form4_1684323794.xml 4 3983
  Complete submission text file 0001628280-23-018556.txt   5451
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 555 CALIFORNIA STREET SUITE 365 SAN FRANCISCO CA 94104
Business Address
NEIL GARRY ARTHUR (Reporting) CIK: 0001586785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 23929648